
Bêta-amyloïde
Les inhibiteurs de bêta-amyloïde sont des composés qui ciblent spécifiquement et inhibent la formation ou l'agrégation des peptides bêta-amyloïdes, impliqués de manière critique dans la pathogenèse de la maladie d'Alzheimer. L'accumulation de plaques bêta-amyloïdes dans le cerveau est l'un des principaux signes pathologiques de la maladie d'Alzheimer, contribuant à la dysfonction neuronale, à la perte synaptique et au déclin cognitif. En empêchant l'agrégation des bêta-amyloïdes, ces inhibiteurs font l'objet de recherches intensives comme agents thérapeutiques potentiels visant à ralentir ou même arrêter la progression de la maladie d'Alzheimer. Chez CymitQuimica, nous proposons une variété d'inhibiteurs de bêta-amyloïde de haute qualité pour soutenir vos recherches sur les troubles neurodégénératifs, l'agrégation des protéines et le développement de thérapies pour la maladie d'Alzheimer.
228 produits trouvés pour "Bêta-amyloïde"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Donanemab
CAS :Donanemab (LY3002813), a humanized IgG1 antibody, targets N-terminal Aβ for potential early Alzheimer's research.Degré de pureté :95%Couleur et forme :LiquidMasse moléculaire :145.36 kDaLecanemab
CAS :Lecanemab (BAN-2401) is an IgG1 monoclonal antibody targeting soluble aggregated beta amyloid (Abeta) for the study of cognitive disorders.Degré de pureté :95% - >95.0% (SDS-PAGE); 100% (SEC-HPLC)Couleur et forme :LiquidMasse moléculaire :147.06 kDaChlorzoxazone
CAS :Chlorzoxazone (Chlorzoxazon) is a Muscle Relaxant. The physiologic effect of chlorzoxazone is by means of Centrally-mediated Muscle Relaxation.Formule :C7H4ClNO2Degré de pureté :99.49% - 99.6%Couleur et forme :SolidMasse moléculaire :169.57Cromolyn sodium
CAS :Cromolyn sodium (FPL-670) is a chromone complex that acts by inhibiting the release of chemical mediators from sensitized mast cells.Formule :C23H14Na2O11Degré de pureté :99.4% - 99.95%Couleur et forme :Colorless Crystals From Ethanol + Ether White Crystalline PowderMasse moléculaire :512.33Glimepiride
CAS :Glimepiride (HOE-490) is a long-acting, third-generation sulfonylurea with hypoglycemic activity.Formule :C24H34N4O5SDegré de pureté :97.84% - 98.87%Couleur et forme :White Cyrstalline SolidMasse moléculaire :490.62LY 2389575 hydrochloride
CAS :LY2389575 hydrochloride is a selective mGlu3 NAM with 190 nM IC50, increases Mrc1, and aids Alzheimer's research.Formule :C15H16BrCl3N4Degré de pureté :99.9%Couleur et forme :SolidMasse moléculaire :438.58Birtamimab
CAS :Birtamimab (NEOD001) is a monoclonal antibody selectively targeting and depleting amyloid protein, used in research on light chain amyloidosis.Degré de pureté :>95%Couleur et forme :LiquidMasse moléculaire :146.44 kDaEprodisate disodium
CAS :Eprodisate disodium (NC-503) is a negatively charged sulfonated inhibitor of fibrillogenesis, that can be used in the treatment of amyloid A (AA) amyloidosis.Formule :C3H6Na2O6S2Degré de pureté :99.88%Couleur et forme :White Coarse PowderMasse moléculaire :248.19Gantenerumab
CAS :Gantenerumab (R-1450) is a humanized antibody targeting amyloid-β (Aβ), used in studies of Alzheimer's disease.Degré de pureté :>95%Couleur et forme :LiquidMasse moléculaire :146.28 kDaALZ-801
CAS :ALZ-801, an oral valine-prodrug of tramiprosate, enhances treatment of Alzheimer's by inhibiting β-amyloid aggregation with better PK and tolerance.Formule :C8H18N2O4SDegré de pureté :99.36%Couleur et forme :SolidMasse moléculaire :238.3β-Amyloid (1-15)
CAS :β-Amyloid (1-15) (Amyloid β-Protein (1-15)) is a fragment of β-amyloid protein used in the study of Alzheimer's disease.Formule :C78H107N25O27Degré de pureté :99.88%Couleur et forme :SolidMasse moléculaire :1826.84Biphenyl-3′,3,4,4′-tetrol
CAS :Biphenyl-3′,3,4,4′-tetrol (BPT) is a potent inhibitor of Aβ40 aggregation and can be utilized in research related to neurodegenerative diseases such as Alzheimer's.Formule :C12H10O4Couleur et forme :SolidMasse moléculaire :218.21Dalidnetug
CAS :Dalidnetug is a humanized monoclonal antibody that targets human β-amyloid precursor protein (APP). By specifically binding to APP, Dalidnetug reduces the production of β-amyloid (Aβ), thereby demonstrating activity in clearing β-amyloid. This compound holds potential for research in Alzheimer's disease.Couleur et forme :LiquidGlycerophosphorylethanolamine (sodium salt)
CAS :Glycerophosphorylethanolamine, a phosphatidylethanolamine metabolite, elevates in Alzheimer's and promotes Aβ40 aggregation.Formule :C5H13NNaO6PCouleur et forme :SolidMasse moléculaire :237.12Pep63
CAS :Pep63, a neuroprotective peptide (VFQVRARTVA), enhances synaptic plasticity and memory. It competitively binds with Aβ1-42 oligomers, thereby inhibiting the formation of Aβ fibrils. Pep63 is employed in research focused on Alzheimer's disease (AD).Formule :C51H87N17O13Couleur et forme :SolidMasse moléculaire :1146.34GRGDSPK acetate
CAS :GRGDSPK acetate shows inhibitory activity against integrin-fibronectin binding and can be used in research on integrins in bone formation and resorption.Formule :C30H53N11O13Degré de pureté :97.9%Couleur et forme :SoildMasse moléculaire :775.81Crenezumab
CAS :Crenezumab (MABT 5102A) is a fully humanized anti-amyloid-beta antibody that binds to multiple forms of amyloid-beta (Aβ) for the study of Alzheimer's disease.Degré de pureté :97.5% (SDS-PAGE); 95.3% (SEC-HPLC) - 97.5% (SDS-PAGE); 95.3% (SEC-HPLC)Couleur et forme :LiquidMasse moléculaire :143.32 kDaDihydrochalcone
CAS :Compound PDK0018, with CAS No. 1083-30-3, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound PDK0018 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.Formule :C15H14OCouleur et forme :SolidMasse moléculaire :210.27SLAFVDVLN
SLAFVDVLN is a peptide molecule that functions as a BACE-1 inhibitor, exhibiting a Ki value of 94 nM. Additionally, SLAFVDVLN is capable of reducing the production of Aβ42.Formule :C45H72N10O14Couleur et forme :SolidMasse moléculaire :977.11FITC-β-Ala-Amyloid β-Protein (1-42)
CAS :FITC-β-Ala-Amyloid β-Protein (1-42) is a polypeptide identified through peptide screening. This screening method predominantly utilizes immunoassays to gather active polypeptides and is used in studying protein interactions, conducting functional analyses, and screening antigen epitopes, with particular application in the research and development of active molecules.Formule :C227H327N57O66S2Masse moléculaire :4971.34251LPYFD-NH2
CAS :neuroprotective peptide that binds to amyloid beta (Aβ)Formule :C33H44N6O8Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :652.74Amyloid-β-IN-1
Amyloid-β-IN-1 (compound 13), a synthetic peptide featuring the hydrophobic C-terminal segment "VVIA-NH2" and its reversed sequence "AIVV-NH2" derived from Aβ 42, acts as an Aβ inhibitor. It effectively inhibits Aβ aggregation and exhibits neuroprotective effects.Formule :C18H35N5O4Masse moléculaire :385.5(Met(O2)35)-Amyloid β-Protein (1-42)
(Met(O2)35)-Amyloid β-Protein (1-42) is a peptide [1] .Formule :C203H311N55O62SCouleur et forme :SolidMasse moléculaire :4546.04β-Amyloid (1-16) acetate
β-Amyloid (1-16) acetate, Fragment of β-Amyloid, N-terminal amino group coordinates metal ions (Cu/Zn), used for Alzheimer's disease research.Formule :C84H119N27O28·xC2H4O2Degré de pureté :99.55%Couleur et forme :SolidMasse moléculaire :1955.04 (free base)β-Amyloid (33-40)
CAS :β-Amyloid (33-40) is a peptide comprising amino acids 33 to 40 of the beta-amyloid protein.Formule :C32H58N8O9SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :730.92JNK3 inhibitor-9
JNK3inhibitor-9 (Compound 24a) is a potent, selective JNK3 inhibitor capable of crossing the blood-brain barrier (BBB), demonstrating an IC50 value of 12 nM. It effectively inhibits GSK3α/β, which is involved in Tau phosphorylation, with IC50 values of 14 nM and 35 nM, respectively. JNK3inhibitor-9 also reduces the phosphorylation of c-Jun and APP and protects neurons from Aβ1-42 toxicity.Formule :C25H27N7O2Couleur et forme :SolidMasse moléculaire :457.528(Gln22)-Amyloid β-Protein (1-42)
CAS :(Gln22)-Amyloid β-Protein (1-42), a Dutch mutation (E22Q) variant of β-Amyloid (1-42), demonstrates increased fibrillogenic and pathogenic characteristics [1].Formule :C203H312N56O59SCouleur et forme :SolidMasse moléculaire :4513.057-Deoxy-trans-dihydronarciclasine
CAS :7-Deoxy-trans-dihydronarciclasine is an alkaloid that functions as a tobacco mosaic virus (TMV) inhibitor with an IC50 of 1.80 μM and also serves as an anti-Formule :C14H15NO6Couleur et forme :SolidMasse moléculaire :293.27β-Amyloid (1-38), mouse, rat
CAS :β-Amyloid (1-38), derived from mice and rats, is a chemical compound comprising 38 amino acids, specifically residues 1-38 of the Aβ peptide.Couleur et forme :SolidAmyloid β-Protein (3-42)
CAS :Amyloid β-Protein (3-42), the precursor of Pyr peptide, serves as the foundation of the amyloid template block in Alzheimer's disease when modified toCouleur et forme :SolidBTA-EG4 hydrate
CAS :BTA-EG4 hydrate aids in diagnosing and mitigating Alzheimer's, enhancing cognitive abilities.Formule :C22H28N2O4SCouleur et forme :SolidMasse moléculaire :416.53Vanutide cridificar
CAS :Vanutide cridificar (ACC-001) is an aminoterminal Aβ1-7 peptide conjugate, employed in Alzheimer’s disease (AD) research [1].Couleur et forme :LiquidSCH-900229
CAS :SCH-900229, a potent presenilin 1 selective γ-secretase inhibitor, used to treat Alzheimer’s Disease.Formule :C21H21ClF2O6S2Couleur et forme :SolidMasse moléculaire :506.97Amyloid β-Protein (1-24)
CAS :Amyloid β-Protein (1-24) is a peptide identified through peptide screening. This tool predominantly employs immunoassays to gather and analyze active peptides. Peptide screening is utilized in studies involving protein interactions, functional analysis, and epitope screening, particularly relevant in the research and development of active molecules.Formule :C130H183N35O40Masse moléculaire :2876.05β-Amyloid (12-28)
CAS :Amyloid β-peptide fragment; minimum section required to bind to brain proteins.Formule :C89H135N25O25Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :1955.18Y040-7904
Y040-7904 is a potential mitochondrial autophagy activator. It enhances mitochondrial autophagy by facilitating the transport of mitochondria to autophagosomes and promoting the fusion of autophagosomes with autolysosomes. Y040-7904 induces mitochondrial autophagy through the SIRT1/FoxO3 pathway and upregulates the levels of Parkin, PINK1, and LC3II/I. Additionally, Y040-7904 reduces Aβ accumulation in both in vitro and in vivo Alzheimer's disease models.Couleur et forme :Odour SolidDDC 2′,3′-O-disulfate
DDC 2′,3′-O-disulfate (compound 4) inhibits the fibrillization and oligomerization of Aβ42, showing promise for Alzheimer's disease (AD) research [1].Formule :C17H16O11S2Couleur et forme :SolidMasse moléculaire :460.43Aβ1-14-εK-KKK-MvF5 Th
Aβ1-14-εK-KKK-MvF5 Th (UB311 immunogen I) is a biologically active peptide and one of the Aβ1–14 targeting peptides (B-cell epitope) used in UB-311.
Formule :C199H318N56O55Masse moléculaire :4372.38081β-Amyloid (1-40)
CAS :Amyloid β1-40 is one of the fragments generated after cleavage of the amyloid peptide precursor protein by β and γ secretases.Formule :C194H295N53O58SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :4329.82γ-Secretase Modulators
CAS :gamma-Secretase Modulators serves as a useful treatment for Alzheimer's disease by inhibiting the production of Amyloid-β.Formule :C26H24F3N3O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :483.48β-Amyloid (35-25)
CAS :β-Amyloid (35-25) is the reverse sequence of β-Amyloid (25-35).Formule :C45H81N13O14SMasse moléculaire :1060.27Aβ-IN-6
Aβ-IN-6 is an orally active compound exhibiting anti-inflammatory, antioxidant, and anti-oligomeric activities, with significant implications for Alzheimer'sFormule :C28H31N3O4Couleur et forme :SolidMasse moléculaire :473.56β-Amyloid (1-20)
CAS :This synthetic peptide consists of amino acids 1 to 20 of beta amyloid protein.Formule :C113H157N31O32Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :2461.7AChE/Aβ-IN-6
BACE1-IN-15 (compound 4j) serves as an effective inhibitor of BACE1 (β-secretase), efficiently mitigating the copper-induced toxicity of Aβ, with an EC50 value of 0.68 μM.Couleur et forme :Odour Solid2002-H20
CAS :2002-H20 is an Aβ42-induced cytotoxicity inhibitor. It acts by binding the Alzheimer's Aβ peptide and reducing its cytotoxicity.Formule :C20H15N3O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :345.358BSBM6
CAS :BSBM6 is an inhibitor of Aβ aggregation and neuronal toxicity that acts by reversing the aggregation and toxicity of amyloid-β peptides.Formule :C23H29N3O5Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :427.49AC 253
CAS :Amylin (AMY3) receptor antagonist; blocks cAMP, Ca2+, PKA, MAPK, Akt, and cFOS activity; prevents Aβ-induced neuronal death. Cyclic AC 253 variant exists.Formule :C122H196N40O39Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :2847.11G923-0271
CAS :G923-0271 is a TDP-43 inhibitor that improves disease phenotypes in TDP-43 nematode models and reduces the overexpression of human TDP-43, ALS FTD.Formule :C28H23FN4OCouleur et forme :SolidMasse moléculaire :450.511H-Indole-3-carboxylic acid, 5-[2-hydroxy-3-[[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino]propoxy]-2-methyl-1-(4-methylphenyl)-, ethyl ester
CAS :Compound 5936-0108对β-淀粉样蛋白可能具有调节作用。
Formule :C26H34N2O7Degré de pureté :99.44%Couleur et forme :SoildMasse moléculaire :486.56Amyloid β Peptide (42-1)(human) acetate
Amyloid β Peptide (42-1)(human) acetate is the inactive form of Amyloid β Peptide (1-42).Degré de pureté :95.20%Couleur et forme :SoildE3 ligase Ligand 41
CAS :E3 Ligase Ligand 41 (Compound SI-13) serves as a ligand for the E3 ubiquitin ligase DCAF16. It is designed to connect with SLF through a linker, enabling the formation of KB03-SLF.Formule :C13H12ClF3N2O4Couleur et forme :SolidMasse moléculaire :352.69FITC-β-Ala-Amyloid β-Protein (1-42) (ammonium)
FITC-β-Ala-Amyloid β-Protein (1-42) (ammonium) is a FITC-labeled amyloid beta monomer, Alzheimer’s research, drug screening, and biomolecular studies.Formule :C227H330N58O66S2Couleur et forme :SolidMasse moléculaire :4991.53β-Amyloid (13-27)
CAS :β-Amyloid (13-27) is a peptide consisting of amino acid of 13 to 27 of beta amyloid protein.Formule :C84H126N24O24Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :1856.05AZD4694 Precursor
CAS :AZD4694 Precursor used for synthesizing [18F]AZD4694, a high-affinity amyloid-β imaging agent.Formule :C22H25N3O7Couleur et forme :SolidMasse moléculaire :443.45β-Amyloid (1-16)
CAS :β-Amyloid (1-16) is an amyloidogenic protein fragment with a sequence derived from β-amyloid.Formule :C84H119N27O28Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :1955.04β-Amyloid (11-22)
CAS :β-Amyloid (11-22) is a peptide fragment of β-Amyloid.Beta-amyloid peptide (Abeta), the major constituent of amyloid plaques in the brains of Alzheimer’sFormule :C70H102N18O18Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :1483.67Aβ-IN-7
Aβ-IN-7 (compound 5a) acts as a potent inhibitor of Aβ aggregation, stabilizing Aβ monomers at 50 μM concentration to prevent them from forming larger oligomersFormule :C14H10N2SCouleur et forme :SolidMasse moléculaire :238.31RI-OR2-TAT
CAS :RI-OR2-TAT is a brain-penetrable inhibitor targeting β-amyloid (β-Amyloid) oligomerization. It is engineered by integrating the HIV protein transduction domain TAT into RI-OR2. RI-OR2-TAT binds to Aβ42 fibrils with a Kd value of 58-125 nM. It reduces Aβ aggregation and plaque levels, diminishes microglial activation and oxidative damage, and enhances the number of young neurons in the dentate gyrus.Formule :C117H201N49O23Couleur et forme :SolidMasse moléculaire :2662.16β-Amyloid (1-43)(human) TFA
β-Amyloid (1-43)(human) TFA exhibits greater aggregation tendencies and heightened toxicity compared to its well-established counterpart, Aβ1-42.Formule :C209H319F3N56O64SCouleur et forme :SolidMasse moléculaire :4729.21GSK-3β inhibitor 27
GSK-3β inhibitor27 (Compound 1c) is a reversible, competitive inhibitor of GSK-3β with an IC50 value of 2.2 μM. It inhibits tau hyperphosphorylation and reduces Aβ protein aggregation, demonstrating metal chelation and neuroprotective potential. GSK-3β inhibitor27 is promising for research into neurodegenerative diseases, such as Alzheimer's disease.Formule :C16H17ClN4O2Couleur et forme :SolidMasse moléculaire :332.79Chemerin-9 (149-157) TFA
Chemerin-9 (149-157) TFA is a peptide located at positions 149-157 of chemerin-9, acting as a ChemR23/CMKLR1 agonist.Formule :C56H67F3N10O15Degré de pureté :99.77%Couleur et forme :SolidMasse moléculaire :1177.18Anti-Amyloid β Antibody (scFv59)
Anti-Amyloid Beta Antibody (scFv59) is a human-derived antibody produced in CHO cells that targets Amyloid-β. For isotype control, please refer to Human IgG1 kappa, Isotype Control.Couleur et forme :Odour LiquidMerinetug
CAS :Merinetug is a humanized IgG1κ antibody that targets Amyloid Beta (Aβ). Its corresponding isotype control is Human IgG1 kappa, Isotype Control.Couleur et forme :LiquidCHF-5022
CAS :CHF-5022 is a nonsteroidal anti-inflammatory drug that selectively inhibits the production of beta-amyloid protein (1-42) (ABETA42).Formule :C17H12F4O2Couleur et forme :SolidMasse moléculaire :324.27Methoxy-X04
CAS :Methoxy-X04, a derivative of Congo red and Chrysamine-G, is a brain-permeable fluorescent probe for amyloid-β (Aβ).
Formule :C23H20O3Degré de pureté :98.96%Couleur et forme :SolidMasse moléculaire :344.4mcK6A1
mcK6A1 serves as an inhibitor of amyloid-β (Aβ) aggregation, selectively binding to the 16KLVFFA21 fragment of Aβ42, leading to the formation of an extended β-sheet structure and preventing the formation of Aβ42 oligomers. This compound is valuable for research into Alzheimer's disease and other amyloid-related disorders.Formule :C71H99N17O16Couleur et forme :SolidMasse moléculaire :1446.65β-Amyloid (4-10)
CAS :Antibodies corresponding to beta-amyloid (4-10) are effective in vivo inhibitors of cytotoxicity, amyloid plaque formation and special memory disturbances inFormule :C39H52N12O12Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :880.92,3-Dehydrosilybin A
CAS :2,3-Dehydrosilybin A is a useful organic compound for research related to life sciences and the catalog number is T125202.Formule :C25H20O10Couleur et forme :SolidMasse moléculaire :480.43β-Amyloid (10-20)
CAS :Amyloid β-Protein (10-20) is a fragment of Amyloid-β peptide, maybe used in the research of neurological disease.Amyloid β protein fragment containing the α-Formule :C71H99N17O16Degré de pureté :98%Couleur et forme :Lyophilized PowderMasse moléculaire :1446.655-FAM-β-Amyloid (1-28)
5-FAM-β-Amyloid (1-28) is a fluorescently-labeled peptide corresponding to the first 28 amino acids of the β-Amyloid protein.Formule :C166H219N41O52Couleur et forme :SolidMasse moléculaire :3620.76p-HTAA
CAS :Pentamer Hydrogen Thiophene Acetic Acid (p-HTAA) is a compound that specifically targets and labels amyloid-beta (Aβ) deposits in the brains of living mice [1].Formule :C24H16O4S5Couleur et forme :SolidMasse moléculaire :528.71β-Amyloid (1-17)
CAS :This synthetic peptide consists of amino acids 1 to 17 of beta amyloid protein. This peptide can be employed in beta amyloid solubility studies.Formule :C90H130N28O29Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :2068.2RAGE antagonist peptide
CAS :RAGE antagonist blocks S100P/A4, HMGB-1; hinders glioma growth, metastasis; reduces PDAC cell growth, NF-κB activity; counters TDI effects in mice.Formule :C57H101N13O17SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :1272.56(Met(O)35)-Amyloid β-Protein (1-42)
(Met(O)35)-Amyloid β-Protein (1-42) represents the oxidized form of Methionine 35 in Aβ42, capable of producing an oligomer size distribution akin to that ofFormule :C203H311N55O61SCouleur et forme :SolidMasse moléculaire :4530.04β-Amyloid Protein Precursor 770 (135-155)
CAS :Beta-Amyloid Protein Precursor 770 (135-155)Aβ Protein Precursor 770 (135-155)
Formule :C116H172N35O31S2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :2617.96β-Amyloid (10-35), amide
CAS :β-Amyloid (10-35), amide, is a chemical compound consisting of 26 amino acids, specifically residues 10-35 of the Aβ peptide.Formule :C133H205N35O36SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :2902.33β-Amyloid (1-28)
CAS :β-Amyloid (1-28) is a β-Amyloid protein fragment involved in metal binding.Formule :C145H209N41O46Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :3262.51Amyloid-Forming peptide GNNQQNY
CAS :Amyloid-Forming peptide GNNQQNY, a biologically active heptapeptide derived from the N-terminal prion-determining domain of yeast Sup35, is instrumental inFormule :C33H48N12O14Couleur et forme :SolidMasse moléculaire :836.81Sabirnetug
CAS :Sabirnetug is a humanized IgG2κ monoclonal antibody that specifically targets the amyloid-β (A4) precursor protein.Couleur et forme :LiquidSQ-3
SQ-3, a quinoline analogue, prefers α-syn (Ki=39.3nM) to Aβ (Ki=230nM), and [18F]SQ3 is a lead for α-syn probes. [1]Formule :C21H21FN2OCouleur et forme :SolidMasse moléculaire :336.4Davunetide
CAS :Davunetide: neuroprotective 8-amino acid peptide, improves daily function in schizophrenia, boosts memory in mild cognitive impairment.Formule :C36H60N10O12Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :824.92BIBD-124
CAS :BIBD-124, with an IC50 value of 9.51 nM, effectively binds to amyloid beta (Aβ) plaques.Formule :C19H24FN3O3Couleur et forme :SolidMasse moléculaire :361.41Aβ-IN-8
Aβ-IN-8, also known as compound 7e, is a potent inhibitor of Aβ aggregation [1].Formule :C22H16F3N3O3SCouleur et forme :SolidMasse moléculaire :459.44β-Amyloid (1-34)
CAS :This is a fragment of beta-amyloid peptide. It has amino acids 1 through 34.Formule :C170H253N47O52Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :3787.2(D-Asp1)-Amyloid β-Protein (1-42)
CAS :(D-Asp1)-Amyloid β-Protein (1-42), a peptide fragment of amyloid β-protein (Aβ), serves as the primary constituent of vascular and parenchymal amyloid depositsFormule :C203H311N55O60SCouleur et forme :SolidMasse moléculaire :4514.04Acetyl-Tau Peptide (273-284) amide
CAS :Acetyl-Tau Peptide (273-284) amide inhibits Ac-Aβ(25–35)-NH2 aggregation and models Aβ/Tau interaction.Formule :C64H116N18O17Couleur et forme :SolidMasse moléculaire :1409.72Biotinoyl tripeptide-1
CAS :Biotinoyl tripeptide-1 can produce hair follicles by promoting scalp micro-circulation and reduce follicle atrophy and aging.Formule :C24H38N8O6SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :566.67β-Amyloid (12-20)
CAS :β-Amyloid (12-20) is a peptide fragment of β-Amyloid.Thsis peptide contain the amino acid residues VFF at position (18-20), suggesting that this triad hasFormule :C57H83N15O11Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :1154.36β-Amyloid (35-42)
CAS :β-Amyloid (35-42) is a peptide derived from the beta-amyloid protein, encompassing amino acids 35 through 42.Formule :C33H60N8O9SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :744.94Aducanumab
CAS :Aducanumab (BIIB037) is an IgG1 antibody targeting amyloid beta to treat Alzheimer's; it's brain-permeable.
Degré de pureté :95% - 97.10%Couleur et forme :LiquidMasse moléculaire :145.93 kDaβ-Amyloid (22-35)
CAS :β-Amyloid (22-35) is a 14-aa peptide, shows aggregates and induces neurotoxicity in the hippocampal cells.Formule :C59H102N16O21SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :1403.62Biotin-β-Amyloid (1-42), human TFA
Biotin-β-Amyloid (1-42), human TFA, also known as Biotin-Amyloid β-Peptide (1-42) (human) TFA, is a biotin-labeled 42-amino acid peptide implicated in theFormule :C215H326F3N57O64S2Couleur et forme :SolidMasse moléculaire :4854.36β-Amyloid (1-9)
CAS :This is an N-terminal fragment of beta amyloid.Formule :C42H60N14O17Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :1033.01β-Amyloid (29-40)
CAS :β-Amyloid (29-40) is a fragment of Amyloid-β peptide.Alzheimer's beta amyloid peptide (29-40/42) C-terminal fragments have physical and chemical propertiesFormule :C49H88N12O13SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :1085.36β-Amyloid (25-35) acetate
β-Amyloid (25-35) acetate is the Aβ(25-35) fragment of amyloid beta peptide, neurotoxicity, construct Alzheimer's disease cell and animal models.Degré de pureté :98.26%β-Amyloid (22-40)
CAS :This synthetic peptide consists of amino acids 22 to 40 of beta amyloid protein.Formule :C78H135N21O26SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :1815.1(Glu20)-Amyloid β-Protein (1-42)
CAS :(Glu20)-Amyloid β-Protein (1-42) represents a variant of amyloid β-protein (Aβ) that fibrillizes more slowly.Formule :C199H309N55O62SCouleur et forme :SolidMasse moléculaire :4495.98β-Amyloid (18-28)
CAS :Intracerebroventricular administration of synthetic peptides Beta-amyloid (12-20), (12-28), and (18-28) causes amnesia in mice.Formule :C55H81N13O18Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :1212.31β-Amyloid (1-11)
CAS :Anionic interaction of Beta-amyloid (1-11) with Factor XII is suspected to cause massive activation of the C4 (complement 4) system in the cerebrospinal fluidFormule :C56H76N16O22Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :1325.3Guluronic acid
CAS :Guluronic acid (G2013) is in hyaluronic acid; a nonsteroidal anti-inflammatory with benefits.Formule :C6H10O7Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :194.139

